136 related articles for article (PubMed ID: 8310000)
21. p53 mutations experimentally induced by 8-methoxypsoralen plus UVA (PUVA) differ from those found in human skin cancers in PUVA-treated patients.
Monti P; Inga A; Aprile A; Campomenosi P; Menichini P; Ottaggio L; Viaggi S; Ghigliotti G; Abbondandolo A; Fronza G
Mutagenesis; 2000 Mar; 15(2):127-32. PubMed ID: 10719037
[TBL] [Abstract][Full Text] [Related]
22. 8-Methoxypsoralen and longwave ultraviolet irradiation are a novel antiproliferative combination for vascular smooth muscle.
March KL; Patton BL; Wilensky RL; Hathaway DR
Circulation; 1993 Jan; 87(1):184-91. PubMed ID: 8419006
[TBL] [Abstract][Full Text] [Related]
23. In vitro PUVA radiation abolishes fluorescent staining with epidermal cell and basement membrane zone markers.
Danno K; Horio T
Br J Dermatol; 1985 Oct; 113(4):391-6. PubMed ID: 2415148
[TBL] [Abstract][Full Text] [Related]
24. Age-related decrease in the inductability of heat shock protein 72 in normal human skin.
Muramatsu T; Hatoko M; Tada H; Shirai T; Ohnishi T
Br J Dermatol; 1996 Jun; 134(6):1035-8. PubMed ID: 8763420
[TBL] [Abstract][Full Text] [Related]
25. Photoinactivation of cultured skin fibroblasts by sublethal doses of 8-methoxypsoralen and long wave ultraviolet light.
Pohl J; Christophers E
J Invest Dermatol; 1978 Nov; 71(5):316-9. PubMed ID: 712107
[TBL] [Abstract][Full Text] [Related]
26. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
Sakuntabhai A; Farr PM; Diffey BL
Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
[TBL] [Abstract][Full Text] [Related]
27. Slt2 (Mpk1) MAP kinase is involved in the response of Saccharomyces cerevisiae to 8-methoxypsoralen plus UVA.
Dardalhon M; Agoutin B; Watzinger M; Averbeck D
J Photochem Photobiol B; 2009 Jun; 95(3):148-55. PubMed ID: 19318276
[TBL] [Abstract][Full Text] [Related]
28. Effect of psoralen and ultraviolet A on platelet functioning: an in vitro and in vivo study.
Procaccini EM; Pandolfi G; Monfrecola G; Rotoli B
Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):4-7. PubMed ID: 1390123
[TBL] [Abstract][Full Text] [Related]
29. Effects of in vitro UVA irradiation and PUVA treatment on membrane fatty acids and activities of antioxidant enzymes in human keratinocytes.
Punnonen K; Jansén CT; Puntala A; Ahotupa M
J Invest Dermatol; 1991 Feb; 96(2):255-9. PubMed ID: 1991986
[TBL] [Abstract][Full Text] [Related]
30. A possible role of prostaglandins in PUVA-induced inflammation: implication by organ cultured skin.
Imokawa G; Tejima T
J Invest Dermatol; 1989 Feb; 92(2):296-300. PubMed ID: 2493056
[TBL] [Abstract][Full Text] [Related]
31. Neoplastic transformation of C3H mouse embryo 10T1/2 cells by 8-methoxypsoralen plus UVA radiation.
Ananthaswamy HN
J Invest Dermatol; 1985 Aug; 85(2):102-6. PubMed ID: 4020157
[TBL] [Abstract][Full Text] [Related]
32. p53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells.
Santamaria AB; Davis DW; Nghiem DX; McConkey DJ; Ullrich SE; Kapoor M; Lozano G; Ananthaswamy HN
Cell Death Differ; 2002 May; 9(5):549-60. PubMed ID: 11973613
[TBL] [Abstract][Full Text] [Related]
33. Effects of 8-methoxypsoralen (8-MOP) and UVA on human lymphocytes.
Lischka G; Bohnert E; Bächtold G; Jung EG
Arch Dermatol Res (1975); 1977 Sep; 259(3):293-8. PubMed ID: 911195
[TBL] [Abstract][Full Text] [Related]
34. The lack of efficacy of 4,6,6'-trimethylangelicin to induce immune suppression in an animal model for photopheresis: a comparison with 8-MOP.
van Iperen HP; Brun BM; Caffieri S; Dall'Acqua F; Gasparro FP; Beijersbergen Henegouwen GM
Photochem Photobiol; 1996 May; 63(5):577-82. PubMed ID: 8628748
[TBL] [Abstract][Full Text] [Related]
35. Immunological detection and visualization of 8-methoxypsoralen-DNA photoadducts.
Yang XY; DeLeo V; Santella RM
Cancer Res; 1987 May; 47(9):2451-5. PubMed ID: 2436765
[TBL] [Abstract][Full Text] [Related]
36. UVA-induced inhibition of proliferation of PHA-stimulated lymphocytes from humans treated with 8-methoxypsoralen.
Scherer R; Kern B; Braun-Falco O
Br J Dermatol; 1977 Nov; 97(5):519-28. PubMed ID: 588465
[TBL] [Abstract][Full Text] [Related]
37. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
[TBL] [Abstract][Full Text] [Related]
38. 5-MOP induced protection against epidermal DNA damage by ultraviolet radiation in human skin.
Young AR; Potten CS; Chadwick CA; Murphy GM; Cohen AJ
Basic Life Sci; 1990; 53():105-16. PubMed ID: 2282027
[No Abstract] [Full Text] [Related]
39. Effects of 8-methoxypsoralen and ultraviolet light A on EGF receptor (HER-1) expression.
Yang XY; Ronai ZA; Santella RM; Weinstein IB
Biochem Biophys Res Commun; 1988 Dec; 157(2):590-6. PubMed ID: 2462418
[TBL] [Abstract][Full Text] [Related]
40. The time of onset and duration of 5-methoxypsoralen photochemoprotection from UVR-induced DNA damage in human skin.
Chadwick CA; Potten CS; Cohen AJ; Young AR
Br J Dermatol; 1994 Oct; 131(4):483-94. PubMed ID: 7947200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
